Literature DB >> 25807889

Factors affecting perioperative mortality in tetralogy of Fallot.

Murat Saygi1, Yakup Ergul1, Hasan Tahsin Tola1, Isa Ozyilmaz1, Erkut Ozturk1, Ismihan Selen Onan2, Sertac Haydin2, Ersin Erek2, Mehmet Yeniterzi2, Alper Guzeltas1, Ender Odemis1, Ihsan Bakir2.   

Abstract

BACKGROUND: We evaluated the preoperative, operative and postoperative risk factors affecting early mortality in patients who underwent total correction of tetralogy of Fallot (TOF).
METHODS: One hundred and twenty-two TOF patients who underwent reparative surgery between January 2010 and November 2013 were enrolled in the study.
RESULTS: Mean patient age and weight was 2.3 ± 2.5 years and 11.3 ± 6.4 kg, respectively. Cardiac catheterization was performed in 101 patients (83%),and coronary anomalies were found in 11 patients. Mean McGoon index, pulmonary annulus z-score, main pulmonary artery z-score, left pulmonary artery z-score and right pulmonary artery z-score were 2.0 ± 0.4, -1.85 ± 1.54, -2.84 ± 2.06, 1.17 ± 1.73, and 0.74 ± 1.57, respectively. Total reparative surgery with a transannular patch was performed in 97 patients (79.6%); the rest underwent valve-sparing surgery. Median duration of postoperative mechanical ventilation, intensive care and hospital stay were 19 h, 3 days and 9 days, respectively. Extracorporeal membrane oxygenation (ECMO) was required in 10 patients in the postoperative early period. Arrhythmias occurring in the early postoperative period were junctional ectopic tachycardia (n = 13), complete atrioventricular block(n = 10; permanent epicardial pacemaker implanted in four) and ventricular tachycardia (n = 4). Nine patients died in the early postoperative period (7.3%). Parameters found to be associated with increased mortality were low preoperative oxygen saturation; high right ventricular/aortic pressure ratio immediately after surgery; presence of coronary anomaly; requirement of postoperative ECMO; and pacemaker (P = 0.02, P = 0.04, P = 0.01, P = 0.0001, P = 0.03, respectively).
CONCLUSIONS: Poor preoperative oxygenation, presence of coronary anomaly, complete AV block in the early postoperative period, high RV pressure and requirement of ECMO appear to be the most significant factors that affect early mortality in the surgical treatment of TOF. Appropriate preoperative assessment, correct surgical strategies and attentive intensive care monitoring are required in order to reduce mortality.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  child; evaluation; perioperative mortality; surgical treatment; tetralogy of Fallot

Mesh:

Year:  2015        PMID: 25807889     DOI: 10.1111/ped.12627

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Pulmonary artery hypoplasia associated with posterior mediastinal hematoma accompanied by a ruptured pseudoaneurysm of the esophageal branch of the left gastric artery.

Authors:  Miho Nitta; Soji Ozawa; Junya Oguma; Akihito Kazuno; Yamato Ninomiya; Takayuki Nishi; Hideo Shimada; Kazunori Myojin
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-02

2.  Basic arterial blood gas biomarkers as a predictor of mortality in tetralogy of Fallot patients.

Authors:  Vandana Bhardwaj; Poonam Malhotra Kapoor; Kalpana Irpachi; Suruchi Ladha; Ujjwal Kumar Chowdhury
Journal:  Ann Card Anaesth       Date:  2017 Jan-Mar

3.  The impact of pulmonary valve-sparing techniques on postoperative early and midterm results in tetralogy of Fallot repair.

Authors:  Selim Aydın; Dilek Suzan; Bahar Temur; Barış Kırat; Müzeyyen İyigün; İbrahim Halil Demir; Ender Ödemiş; Ersin Erek
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

Review 4.  Surgical outcomes in complex adult congenital heart disease: a brief review.

Authors:  Alice Chan; Amna Aijaz; Ali N Zaidi
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

Review 5.  Current outcomes and treatment of tetralogy of Fallot.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2019-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.